{
    "paper_id": "PMC5101293",
    "metadata": {
        "title": "Acyclic nucleoside phosphonates containing the amide bond",
        "authors": [
            {
                "first": "Iwona",
                "middle": [
                    "E."
                ],
                "last": "G\u0142owacka",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Dorota",
                "middle": [
                    "G."
                ],
                "last": "Piotrowska",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Graciela",
                "middle": [],
                "last": "Andrei",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Dominique",
                "middle": [],
                "last": "Schols",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Robert",
                "middle": [],
                "last": "Snoeck",
                "suffix": "",
                "email": null,
                "affiliation": {}
            },
            {
                "first": "Andrzej",
                "middle": [
                    "E."
                ],
                "last": "Wr\u00f3blewski",
                "suffix": "",
                "email": "andrzej.wroblewski@umed.lodz.pl",
                "affiliation": {}
            }
        ]
    },
    "body_text": [
        {
            "text": "The search for new compounds endowed with antiviral activity has been underway for decades. Several research groups have been active in this field, both in academia and pharmaceutical industry. Despite these efforts, for many viruses efficient drugs have not been yet discovered. In addition, anticancer drugs available so far exhibit limited applicability. The high mutation rate observed for some viruses makes the issue highly complex. Within medications applied to treat viral infections, acyclic nucleoside phosphonates (ANPs) play an important role [1\u20133]. The prototype of the acyclic nucleoside phosphonates (ANPs), (S)-HPMPA (3), was never commercialized but it gave rise to three marketed products [cidofovir (4), adefovir (1), and tenofovir (2)] that are often prescribed by physicians. So far known structural modifications of compounds 1\u20134 accomplished within a chain connecting nucleobase and phosphonic acid moieties did not lead to discovery of analogs having higher antiviral activity (Fig. 1).\n",
            "cite_spans": [
                {
                    "start": 556,
                    "end": 557,
                    "mention": "1",
                    "ref_id": "BIBREF0"
                },
                {
                    "start": 558,
                    "end": 559,
                    "mention": "3",
                    "ref_id": "BIBREF22"
                }
            ],
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 1007,
                    "end": 1008,
                    "mention": "1",
                    "ref_id": "FIGREF0"
                }
            ]
        },
        {
            "text": "Analysis of the mechanism of action of ANPs [3, 4] allows to conclude that within structures of newly designed analogs of ANPs, the following fragments have to be installed: (1) a phosphonate unit (P\u2013CH2) which prevents enzymatic hydrolysis of the P\u2013O bond present in natural phosphates, while being capable of further phosphorylation; (2) canonical nucleobases or their very close structurally heterocyclic systems to assure efficient interactions with the complementary nucleobases of the other polynucleotide chain; (3) a linker to adjust a distance between a nucleobase and a phosphorus atom which should contain four atoms considered optimal at this moment.",
            "cite_spans": [
                {
                    "start": 45,
                    "end": 46,
                    "mention": "3",
                    "ref_id": "BIBREF22"
                },
                {
                    "start": 48,
                    "end": 49,
                    "mention": "4",
                    "ref_id": "BIBREF31"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Taking into account high antiviral activity of compounds 1\u20134, one may be interested in specific interactions of oxygen lone pairs and also of the entire phosphonomethoxy (P\u2013CH2\u2013O) fragment. The oxygen atom located within a P\u2013CH2\u2013O\u2013CHR\u2013 fragment can serve as a lone pair donor in intermolecular interactions, and single bonds connecting atoms in the linker ensure free rotation. To modify interactions of atoms located in the linker it is reasonable to consider replacing selected fragments of the linker for another moiety.",
            "cite_spans": [],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "During studies on biological activity of peptides, replacements of the amide [\u2013C(O)\u2013NH\u2013] residue for several isosteric fragments (including a methylene ether [\u2013CH2\u2013O\u2013] moiety) are commonly applied [5\u20137]. This particular replacement allows to preserve steric conformity of both bonding systems but essentially influences donor\u2013acceptor interactions and possibilities of a rotation around the specific bonds within the linker [completely free around the CH2\u2013O bond (11.3 kJ/mol\u2014barrier to rotation) as compared to the hindered around the C(O)\u2013NH bond (88 kJ/mol\u2014barrier to rotation)]. In general, this isosteric replacement diminishes affinity of modified peptides in comparison with the natural ones.",
            "cite_spans": [
                {
                    "start": 198,
                    "end": 199,
                    "mention": "5",
                    "ref_id": "BIBREF32"
                },
                {
                    "start": 200,
                    "end": 201,
                    "mention": "7",
                    "ref_id": "BIBREF34"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "The proposed structural modification of ANPs 1\u20134 relies on the incorporation of a specific fragment which will be able to increase donor\u2013acceptor interactions within the linker. In our first approach, the [P\u2013CH2\u2013O\u2013CHR\u2013] fragment will be replaced with the amide [P\u2013CH2\u2013HN\u2013C(O)\u2013] residue to provide amides 5 (Scheme 1). In addition, a part of the linker containing the amide bond becomes rigid and thus may influence the activity of modified ANPs.\n",
            "cite_spans": [],
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 314,
                    "end": 315,
                    "mention": "1",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "Several decades ago, a concept of phosphonate peptide nucleic acids (PPNA) was introduced [8\u201311] and a variety of related monomers 6 were synthesized, however, limited to aminomethyl- and aminoethylphosphonate derivatives. Our interest in the synthesis of phosphonates of general formula 5 significantly extends structural diversity of potential new monomers 6 primarily in the aminoalkylphosphonate fragment.",
            "cite_spans": [
                {
                    "start": 91,
                    "end": 92,
                    "mention": "8",
                    "ref_id": "BIBREF35"
                },
                {
                    "start": 93,
                    "end": 95,
                    "mention": "11",
                    "ref_id": "BIBREF2"
                }
            ],
            "section": "Introduction",
            "ref_spans": []
        },
        {
            "text": "Herein, we wish to describe our studies on the synthesis and the biological activity of the amides 5. The synthetic strategy involves the formation of the amide bond from the respective acetic acid derivatives 8 and \u03c9-aminophosphonates 7 (Scheme 1).",
            "cite_spans": [],
            "section": "Introduction",
            "ref_spans": [
                {
                    "start": 246,
                    "end": 247,
                    "mention": "1",
                    "ref_id": null
                }
            ]
        },
        {
            "text": "We also aimed to study the conformational behavior of an acyclic linker connecting a phosphorus atom and the amide nitrogen for future structure\u2013activity considerations. Free rotation around P\u2013CH2 and H2C\u2013NH bonds in phosphonates 17a\u201325a, as depicted by 26a in Fig. 2, is evidenced from the vicinal HNCH couplings of 5.9 Hz observed in the spectra of 21a and 25a taken in chloroform-d and DMSO-d\n6, respectively. In solutions in these solvents as well as in methanol-d\n4\nH\n2CP are equivalent since they always appeared as a one doublet from two-bond HP coupling of 11.8 Hz.\n",
            "cite_spans": [],
            "section": "Conformational analysis ::: Results and discussion",
            "ref_spans": [
                {
                    "start": 266,
                    "end": 267,
                    "mention": "2",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "Structure 26b (Fig. 2) summarizes conformational flexibility of phosphonates 17b\u201325b which is proved by the observation of the vicinal H2C\u2013CH2 couplings of 7.6 Hz.",
            "cite_spans": [],
            "section": "Conformational analysis ::: Results and discussion",
            "ref_spans": [
                {
                    "start": 20,
                    "end": 21,
                    "mention": "2",
                    "ref_id": "FIGREF1"
                }
            ]
        },
        {
            "text": "Since 13C NMR spectra of phosphonates 17c\u201325c showed large values (18.1\u201319.6 Hz) of vicinal PCCC couplings, the antiperiplanar disposition of the P\u2013CC\u2013CH\n2 groups is proposed and represented by the Newman projection 26c.",
            "cite_spans": [],
            "section": "Conformational analysis ::: Results and discussion",
            "ref_spans": []
        },
        {
            "text": "Although significant values (11.0\u201312.1 Hz) were observed in the 13C NMR spectra of phosphonates 17d\u201325d for vicinal PCOC couplings, they cannot be applied with confidence to discuss conformational behavior of the \u2013CH2OCH2CH2\u2013 linkage since the angular dependence within a P\u2013C\u2013O\u2013C framework has not yet been established.",
            "cite_spans": [],
            "section": "Conformational analysis ::: Results and discussion",
            "ref_spans": []
        },
        {
            "text": "All phosphonates 17\u201325 were evaluated for inhibitory activity against a wide variety of DNA and RNA viruses, using the following cell-based assays: (a) human embryonic lung (HEL) cells: herpes simplex virus-1 (KOS strain), herpes simplex virus-2 (G strain), thymidine kinase-deficient (acyclovir resistant) herpes simplex virus-1 (TK\u2212 KOS ACVr strain), vaccinia virus, adenovirus-2, vesicular stomatitis virus, cytomegalovirus (AD-169 strain and Davis strain), varicella-zoster virus (TK+ VZV strain and TK\u2212 VZV strain); (b) HeLa cell cultures: vesicular stomatitis virus, Coxsackie virus B4 and respiratory syncytial virus; (c) Vero cell cultures: parainfluenza-3 virus, reovirus-1, Sindbis virus, Coxsackie virus B4, Punta Toro virus, yellow fever virus; (d) CrFK cell cultures: feline corona virus (FIPV) and feline herpes virus (FHV); (e) MDCK cell cultures: influenza A virus (H1N1 and H3N2 subtypes) and influenza B virus. Ganciclovir, cidofovir, acyclovir, brivudine, zalcitabine, zanamivir, alovudine, amantadine, rimantadine, ribavirin, dextran sulfate (molecular weight 10,000, DS-10000), mycophenolic acid, Hippeastrum hybrid agglutinin (HHA) and Urtica dioica agglutinin (UDA) were used as the reference compounds. The antiviral activity was expressed as the EC50: the compound concentration required to reduce virus plaque formation (VZV) by 50% or to reduce virus-induced cytopathogenicity by 50% (other viruses). None of the tested compounds showed appreciable antiviral activity toward any of the tested DNA and RNA viruses at concentrations up to 100 \u03bcM, nor affected cell morphology of HEL, HeLa, Vero, MDCL, and CrFK cells.",
            "cite_spans": [],
            "section": "Antiviral activity ::: Results and discussion",
            "ref_spans": []
        },
        {
            "text": "The 50% cytostatic inhibitory concentration (IC50) causing a 50% decrease in cell proliferation was determined against murine leukemia L1210, human lymphocyte CEM, human cervix carcinoma HeLa, and human dermal microvascular endothelial cells (HMEC-1).",
            "cite_spans": [],
            "section": "Cytostatic activity ::: Results and discussion",
            "ref_spans": []
        },
        {
            "text": "Among all tested compounds, only phosphonate 18d showed slight antiproliferative activity toward L1210 (IC50 = 89 \u00b1 16 \u03bcM) and HeLa cells (IC50 = 194 \u00b1 19 \u03bcM) and thus enlarges a collection of 5-fluorouracil derivatives which together with the parent compound have been widely clinically applied in therapies of various cancers [35]. Furthermore, the closest structural analog of 18d (compound 18e) was found active in vitro against L1210 cells at concentration of 15 \u03bcM [36] (Fig. 3).\n",
            "cite_spans": [
                {
                    "start": 329,
                    "end": 331,
                    "mention": "35",
                    "ref_id": "BIBREF28"
                },
                {
                    "start": 472,
                    "end": 474,
                    "mention": "36",
                    "ref_id": "BIBREF29"
                }
            ],
            "section": "Cytostatic activity ::: Results and discussion",
            "ref_spans": [
                {
                    "start": 482,
                    "end": 483,
                    "mention": "3",
                    "ref_id": "FIGREF2"
                }
            ]
        },
        {
            "text": "Replacement of the P\u2013CH2\u2013O\u2013CHR\u2013 fragment in ANPs (e.g., acyclovir, tenofovir) by the P\u2013CH2\u2013HN\u2013C(O)\u2013 residue was introduced to study the influence of a linker rigidity and changes in donor\u2013acceptor properties. To elaborate an appropriate synthetic methodology, a series of the 36 respective phosphonates as O,O-diethyl esters was prepared in good yields by the EDC-induced coupling of the straight chain \u03c9-aminophosphonates and nucleobase-derived acetic acids. Besides the rigidity of the amide bond based on the 1H and 13C NMR data, it was concluded that the unrestricted rotation within the methylene (series a) and 1,2-ethylidene (series b) linkers takes place while for phosphonates containing 1,3-propylidene (series c) fragments antiperiplanar disposition of the bulky O,O-diethylphosphonate and substituted amidomethyl groups was observed. The phosphonates 17a\u201325d appeared inactive in antiviral assays against a wide variety of DNA and RNA viruses at concentrations up to 100 \u03bcM. Marginal antiproliferative activity (L1210, IC50 = 89 \u00b1 16 \u03bcM and HeLa, IC50 = 194 \u00b1 19 \u03bcM) was noticed for the phosphonate 18d derived from (5-fluorouracyl-1-yl)acetic acid and O,O-diethyl (2-aminoethoxy)methylphosphonate. Studies on the analogous phosphonates containing functionalized linkages are currently ongoing in our laboratory and the most active diethyl esters will be transformed into the free ANP and further derivatized to selected prodrug phosphonates [37].",
            "cite_spans": [
                {
                    "start": 1455,
                    "end": 1457,
                    "mention": "37",
                    "ref_id": "BIBREF30"
                }
            ],
            "section": "Conclusion",
            "ref_spans": []
        },
        {
            "text": "A solution of 0.100 g aminophosphonate 7a (0.598 mmol) in 2 cm3 DMF containing 0.100 g (thymine-1-yl)acetic acid (12, 0.544 mmol) was cooled to 0 \u00b0C and 0.152 cm3 TEA (1.09 mmol) followed by a 0.481 cm3 of a 50% solution of T3P\u00ae in DMF (0.816 mmol) were added. The reaction mixture was stirred at room temperature for 24 h, concentrated in vacuo and treated with 5 cm3 water. A solid was filtered off, air dried, and subjected to chromatography on a silica gel column with chloroform\u2013methanol mixtures (20:1, 10:1 v/v) to give pure compound 20a (0.072 g, 40% yield) as a white powder.",
            "cite_spans": [],
            "section": "General procedure A ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "To a solution of aminophosphonates 7a\u20137d (1.00 mmol) in 2 cm3 DMF or chloroform the respective acetic acids 9\u201316 (1.00 mmol), EDC \u00d7 HCl (1.00 mmol), and TEA (1.00 mmol) were added. The reaction mixture was stirred at room temperature for 48\u201372 h and then concentrated in vacuo. The residue was chromatographed on a silica gel column with chloroform\u2013methanol mixtures and crystallized from the appropriate solvents.",
            "cite_spans": [],
            "section": "General procedure B ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.100 g diethyl 2-aminomethylphosphonate (7a, 0.60 mmol) and 0.097 g (uracil-1-yl)acetic acid (9, 0.60 mmol) in the presence of 0.115 g EDC \u00d7 HCl (0.60 mmol) and 0.083 cm3 TEA (0.60 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) to give pure compound 17a (0.106 g, 55% yield) as a white powder. M.p.: 215\u2013217 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3254, 3058, 2997, 2882, 2831, 1703, 1679, 1259, 1193, 1031 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 7.56 (d, 3\nJ = 7.9 Hz, 1H, HC6), 5.71 (d, 3\nJ = 7.9 Hz, 1H, HC5), 4.51 (d, 3\nJ = 1.4 Hz, 2H, C(O)CH2), 4.26\u20134.11 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.78 (d, 2\nJ = 11.8 Hz, 2H, PCH2N), 1.37 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.92 (d, J = 3.7 Hz), 165.38, 151.36, 146.37, 100.85, 62.79 (d, J = 6.5 Hz, POC), 49.56, 34.23 (d, J = 158.5 Hz, PC), 15.28 (d, J = 5.8 Hz, POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 23.6 ppm.",
            "cite_spans": [],
            "section": "Diethyl [2-(3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]methylphosphonate (17a, C11H18N3O6P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.100 g diethyl 2-aminoethylphosphonate (7b, 0.550 mmol) and 0.094 g (uracil-1-yl)acetic acid (9, 0.55 mmol) in the presence of 0.105 g EDC \u00d7 HCl (0.550 mmol) and 0.077 cm3 TEA (0.55 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) to give pure compound 17b (0.095 g, 52% yield) as a white powder. M.p.: 138\u2013140 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3340, 2986, 2953, 2896, 2826, 1696, 1673, 1236, 1024 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 7.52 (d, 3\nJ = 7.9 Hz, 1H, HC6), 5.70 (d, 3\nJ = 7.9 Hz, 1H, HC5), 4.43 (s, 2H, C(O)CH2), 4.18\u20134.10 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.48 (dt, J = 12.3 Hz, J = 7.6 Hz, 2H, PCH2CH\n2), 2.10 (dt, J = 15.3 Hz, J = 7.6 Hz, 2H, PCH\n2), 1.36 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.92, 165.38, 151.49, 146.38, 100.95, 62.09 (d, J = 6.5 Hz, POC), 49.81, 33.41, 24.87 (d, J = 139.0 Hz, PC), 15.31 (d, J = 6.2 Hz, POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 29.34 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]ethylphosphonate (17b, C12H20N3O6P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.080 g diethyl 3-aminopropylphosphonate (7c, 0.41 mmol) and 0.070 g (uracil-1-yl)acetic acid (9, 0.41 mmol) in the presence of 0.079 g EDC \u00d7 HCl (0.41 mmol) and 0.057 cm3 TEA (0.41 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and the selected fractions were crystallized from ethyl acetate to give pure compound 17c (0.046 g, 32% yield) as a white solid. M.p.: 120\u2013122 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3327, 3101, 2989, 2937, 2885, 2835, 1697, 1670, 1563, 1240, 1039 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 7.56 (d, 3\nJ = 7.9 Hz, 1H, HC6), 5.70 (d, 3\nJ = 7.9 Hz, 1H, HC5), 4.45 (s, 2H, C(O)CH2), 4.28\u20134.03 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.30 (t, J = 6.9 Hz, 2H, PCH2CH2CH\n2), 1.95\u20131.68 (m, 4H, PCH\n2CH\n2), 1.36 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.08, 165.41, 151.44, 146.46, 100.85, 61.90 (d, J = 6.0 Hz, POC), 50.00, 39.34 (d, J = 18.8 Hz, PCCC), 22.13 (d, J = 4.5 Hz, PCC), 21.91 (d, J = 142.1 Hz, PC), 15.30 (d, J = 5.7 Hz, POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 33.69 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]propylphosphonate (17c, C13H22N3O6P\u00a0\u00d7\u00a0H2O) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.050 g diethyl (2-aminoethoxy)methylphosphonate (7d, 0.237 mmol) and 0.040 g (uracil-1-yl)acetic acid (9, 0.237 mmol) in the presence of 0.045 g EDC \u00d7 HCl (0.237 mmol) and 0.033 cm3 TEA (0.237 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and the selected fractions were crystallized from ethyl acetate\u2013hexane mixture to give pure compound 17d (0.060 g, 70% yield) as white needles. M.p.: 116\u2013117 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3320, 3098, 2984, 2980, 2951, 2888, 2821, 1695, 1673, 1257, 1031 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 7.56 (d, 3\nJ = 7.9 Hz, 1H, HC6), 5.70 (d, 3\nJ = 7.9 Hz, 1H, HC5), 4.48 (s, 2H, C(O)CH2), 4.29\u20134.14 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.92 (d, J = 8.5 Hz, 2H, PCH2O), 3.69 (t, J = 5.3 Hz, 2H, PCH2OCH\n2CH2), 3.46 (t, J = 5.3 Hz, 2H, PCH2OCH2CH\n2), 1.38 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.04, 165.39, 151.44, 146.44, 100.83, 71.44 (d, J = 12.1 Hz, PCOC), 64.19 (d, J = 166.9 Hz, PC), 62.77 (d, J = 6.6 Hz, POC), 49.70, 38.96, 15.36 (d, J = 5.5 Hz, POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 23.10 ppm.",
            "cite_spans": [],
            "section": "Diethyl [2-[2-(3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]ethoxy]methyl phosphonate (17d, C13H22N3O7P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.107 g diethyl aminomethylphosphonate (7a, 0.640 mmol) and 0.120 g (5-fluorouracil-1-yl)acetic acid (10, 0.640 mmol) in the presence of 0.123 g EDC \u00d7 HCl (0.640 mmol) and 0.089 cm3 TEA (0.64 mmol) according to the general procedure B was filtered and crystallized from a methanol\u2013diethyl ether mixture to give pure compound 18a (0.127 g, 59% yield) as a white powder. M.p.: 205\u2013208 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3224, 3061, 3000, 2941, 2830, 1738, 1700, 1034 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 7.80 (d, J = 6.2 Hz, 1H, HC6), 4.46 (s, 2H, C(O)CH2), 4.20\u20134.15 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.76 (d, J = 11.8 Hz, 2H, PCH2), 1.36 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.78 (d, 3\nJ = 3.2 Hz, C(O)NHCP), 158.54 (d, J = 26.2 Hz), 150.12, 140.17 (d, J = 232.5 Hz), 130.30 (d, J = 34.1 Hz), 62.82 (d, J = 6.0 Hz, POC), 49.56, 34.27 (d, J = 158.6 Hz, PC), 15.28 (d, J = 5.8 Hz, POCC) ppm; 31P NMR (273 MHz, CD3OD): \u03b4 = 22.71 ppm.",
            "cite_spans": [],
            "section": "Diethyl [2-(5-fluoro-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]methylphosphonate (18a, C11H17FN3O6P\u00a0\u00d7\u00a00.5H2O) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.114 g diethyl 2-aminoethylphosphonate (7b, 0.629 mmol) and 0.118 g (5-fluorouracil-1-yl)acetic acid (10, 0.629 mmol) in the presence of 0.121 g EDC \u00d7 HCl (0.629 mmol) and 0.088 cm3 TEA (0.63 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (100:1, 50:1, 20:1 v/v) and the selected fractions were crystallized from a methanol\u2013diethyl ether mixture to give pure compound 18b (0.131 g, 59% yield) as a white solid. M.p.: 185\u2013186 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3241, 3063, 3035, 2982, 2930, 1742, 1657, 1630, 1215, 1056 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 7.80 (d, J = 6.2 Hz, 1H, HC6), 4.41 (s, 2H, C(O)CH2), 4.19\u20134.10 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.51-3.46 (m, 2H, PCH2CH\n2), 2.13\u20132.08 (m, 2H, 2H, PCH\n2), 1.36 (t, J = 7.1 Hz, 3H, POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.76, 158.53 (d, J = 25.6 Hz), 150.19, 140.24 (d, J = 231.0 Hz), 130.27 (d, J = 34.1 Hz), 62.07 (d, J = 6.6 Hz, POC), 49.78, 33.40 (d, J = 1.6 Hz), 24.86 (d, J = 139.6 Hz, PC), 15.28 (d, J = 5.7 Hz, POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 29.30 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(5-fluoro-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]ethylphosphonate (18b, C12H19FN3O6P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.055 g diethyl 3-aminopropylphosphonate (7c, 0.28 mmol) and 0.053 g (5-fluorouracil-1-yl)acetic acid (10, 0.28 mmol) in the presence of 0.054 g EDC \u00d7 HCl (0.28 mmol) and 0.040 cm3 TEA (0.28 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and the selected fractions were crystallized from a methanol\u2013diethyl ether mixture to give pure compound 18c (0.048 g, 47% yield) as a white solid. M.p.: 143\u2013144 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3240, 3096, 3032, 2996, 2955, 2940, 2884, 2835, 1740, 1669, 1677, 1240, 1033 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 7.81 (d, J = 6.3 Hz, 1H, HC6), 4.40 (s, 2H, C(O)CH2), 4.17\u20134.07 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.33 (t, J = 6.4 Hz, 2H, PCH2CH2CH\n2), 1.88\u20131.77 (m, 4H, PCH\n2CH\n2), 1.35 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.91, 158.58 (d, J = 25.7 Hz), 150.18, 140.20 (d, J = 232.5 Hz), 130.40 (d, J = 33.2 Hz), 61.90 (d, J = 6.6 Hz, POC), 50.01, 39.36 (d, J = 18.7 Hz, PCCC), 22.11 (d, J = 3.9 Hz, PCC), 21.91 (d, J = 141.9 Hz, PC), 15.32 (d, J = 5.7 Hz, POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 32.80 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(5-fluoro-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]propylphosphonate (18c, C13H21FN3O6P\u00a0\u00d7\u00a00.5H2O) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.076 g diethyl 3-aminopropylphosphonate (18d, 0.360 mmol) and 0.068 g (5-fluorouracil-1-yl)acetic acid (10, 0.36 mmol) in the presence of 0.069 g EDC \u00d7 HCl (0.36 mmol) and 0.050 cm3 TEA (0.360 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and the selected fractions were crystallized from ethyl acetate to give pure compound 18d (0.83 g, 61% yield) as a white solid. M.p.: 69\u201370 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3362, 3169, 3058, 2995, 2933, 2825, 1699, 1662, 1242, 1024, 974 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 7.83 (d, J = 6.2 Hz, 1H, HC6), 4.44 (s, 2H, C(O)CH2), 4.29\u20134.14 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.92 (d, J = 8.5 Hz, 2H, PCH2O), 3.70 (t, J = 5.3 Hz, 2H, PCH2OCH\n2CH2), 3.46 (t, J = 5.3 Hz, 2H, PCOCH2CH\n2), 1.38 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.89, 158.09 (d, J = 25.7 Hz), 150.18, 140.19 (d, J = 232.5 Hz), 130.36 (d, J = 33.2 Hz), 71.43 (d, J = 12.1 Hz, PCOC), 64.18 (d, J = 167.6 Hz, PC), 62.79 (d, J = 6.6 Hz, POC), 49.70, 38.97, 15.36 (d, J = 5.6 Hz, POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 23.11 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(5-fluoro-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido)ethoxy]methylphosphonate (18d, C13H21FN3O7P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.099 g diethyl aminomethylphosphonate (7a, 0.59 mmol) and 0.088 g, (5-bromouracil-1-yl)acetic acid (11, 0.59 mmol) in the presence of 0.114 g EDC \u00d7 HCl (0.592 mmol) and 0.083 cm3 TEA (0.59 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and the selected fractions were crystallized from an ethanol\u2013diethyl ether mixture to give pure compound 19a (0.094 g, 40% yield) as a white solid. M.p.: 211\u2013213 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3225, 3065, 2992, 2941, 2830, 1698, 1680, 1024, 623 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 8.04 (s, 1H, HC6), 4.53 (d, J = 1.5 Hz, 2H, C(O)CH2), 4.26\u20134.11 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.78 (d, J = 11.8 Hz, 2H, PCH2), 1.37 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.70 (d, J = 3.6 Hz), 160.72, 150.80, 145.79, 95.09, 62.83 (d, J = 6.0 Hz, POC), 49.60, 34.27 (d, J = 158.6 Hz, PC), 15.29 (d, J = 5.7 Hz, POCC) ppm; 31P NMR (273 MHz, CD3OD): \u03b4 = 22.70 ppm.",
            "cite_spans": [],
            "section": "Diethyl [2-(5-bromo-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]methylphosphonate (19a, C11H17BrN3O6P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.078 g diethyl 2-aminoethylphosphonate (7b, 0.431 mmol) and 0.107 g (5-bromouracil-1-yl)acetic acid (11, 0.431 mmol) in the presence of 0.083 g EDC \u00d7 HCl (0.431 mmol) and 0.060 cm3 TEA (0.431 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (100:1, 50:1, 20:1 v/v) and the selected fractions were crystallized from ethyl acetate to give pure compound 19b (0.082 g, 46% yield) as white needles. M.p.: 211\u2013213 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3224, 3164, 3067, 2994, 2822, 1708, 1680, 1216, 1019, 619 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 8.04 (s, 1H, HC6), 4.46 (s, 2H, C(O)CH2), 4.24\u20134.07 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.56-3.43 (m, 2H, PCH2CH\n2), 2.20\u20132.04 (m, 2H, 2H, PCH\n2), 1.38 (t, J = 7.1 Hz, 3H, POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.68, 160.72, 150.89, 145.78, 95.17, 62.09 (d, J = 6.6 Hz, POC), 49.83, 33.43 (d, J = 1.7 Hz), 24.86 (d, J = 139.5 Hz, PC), 15.29 (d, J = 5.7 Hz, POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 30.20 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(5-bromo-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]ethylphosphonate (19b, C12H19BrN3O6P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.151 g diethyl 3-aminopropylphosphonate (7c, 0.774 mmol) and 0.115 g (5-bromouracil-1-yl)acetic acid (11, 0.774 mmol) in the presence of 0.148 g EDC \u00d7 HCl (0.774 mmol) and 0.108 cm3 TEA (0.774 mmol) according to the general procedure B was chromatographed with dichloromethane\u2013methanol mixtures (100:1, 50:1, 20:1 v/v) and the selected fractions were crystallized from a methanol\u2013diethyl ether mixture to give pure compound 19c (0.063 g, 20% yield) as a white solid. M.p.: 164\u2013166 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3259, 3039, 2830, 2835, 1720, 1681, 1235, 1033 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 8.05 (s, 1H, HC6), 4.46 (s, 2H, C(O)CH2), 4.21\u20134.04 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.33 (t, J = 6.4 Hz, 2H, PCH2CH2CH\n2), 1.98\u20131.72 (m, 4H, PCH\n2CH\n2), 1.36 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.84, 160.77, 150.87, 145.88, 95.09, 61.89 (d, J = 6.6 Hz, POC), 50.05, 39.36 (d, J = 18.7 Hz, PCCC), 22.09 (d, J = 4.7 Hz, PCC), 21.90 (d, J = 141.9 Hz, PC), 15.30 (d, J = 7.6 Hz, POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 33.70 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(5-bromo-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido]propylphosphonate (19c, C13H21BrN3O6P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.170 g diethyl (2-aminoethoxy)methylphosphonate (7d, 0.805 mmol) and 0.200 g (5-bromouracil-1-yl)acetic acid (11, 0.805 mmol) in the presence of 0.154 g EDC \u00d7 HCl (0.805 mmol) and 0.112 cm3 TEA (0.805 mmol) according to the general procedure C for 1.0 h was chromatographed with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and the selected fractions were crystallized from ethyl acetate to give pure compound 19d (0.172 g, 48% yield) as a white powder. M.p.: 149\u2013151 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3323, 3107, 2990, 2867, 2820, 2768, 1711, 1669, 1237, 1034, 972 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 8.04 (s, 1H, HC6), 4.49 (s, 2H, C(O)CH2), 4.29\u20134.14 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.92 (d, J = 8.5 Hz, 2H, PCH2O), 3.69 (t, J = 5.3 Hz, 2H, PCH2OCH\n2CH2), 3.46 (t, J = 5.3 Hz, 2H, PCOCH2CH\n2), 1.38 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.82, 160.77, 150.88, 145.90, 95.06, 71.44 (d, J = 12.0 Hz, PCOC), 64.19 (d, J = 167.6 Hz, PC), 62.80 (d, J = 6.6 Hz, POC), 49.77, 39.00, 15.40 (d, J = 5.6 Hz, POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 23.11 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(5-bromo-3,4-dihydro-2,4-dioxopyrimidin-1(2H)-yl)acetamido)ethoxy]methylphosphonate (19d, C13H21BrN3O7P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.048 g diethyl aminomethylphosphonate (7a, 0.287 mmol) and 0.053 g (thymine-1-yl)acetic acid (12, 0.287 mmol) in the presence of 0.055 g EDC \u00d7 HCl (0.287 mmol) and 0.040 cm3 TEA (0.287 mmol) according to the general procedure C was chromatographed with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) to give pure compound 20a (0.060 g, 63% yield) as a white powder. M.p.: 211.5\u2013212.5 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3227, 3058, 2986, 2932, 2833, 1697, 1653, 1242, 1200, 1020 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 7.41 (q, 4\nJ = 1.2 Hz, 1H, HC6), 4.48 (d, J = 1.5 Hz, 2H, C(O)CH2), 4.28\u20134.11 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.77 (d, J = 11.8 Hz, 2H, PCH2), 1.91 (d, 4\nJ = 1.2 Hz, 3H, CH3), 1.37 (t, J = 6.8 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.11 (d, 3\nJ = 4.2 Hz, C(O)NHCP), 165.58, 151.57, 142.15, 109.66, 62.80 (d, J = 6.5 Hz, POC), 49.39, 34.23 (d, J = 158.5 Hz, PC), 15.28 (d, J = 5.7 Hz, POCC), 10.78 ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 23.6 ppm.",
            "cite_spans": [],
            "section": "Diethyl [2-(3,4-dihydro-5-methyl-2,4-dioxopyrimidin-1(2H)-yl)acetamido]methylphosphonate (20a, C13H22N3O6P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.100 g diethyl 2-aminoethylphosphonate (7b, 0.550 mmol) and 0.101 g (thymine-1-yl)acetic acid (12, 0.550 mmol) in the presence of 0.105 g EDC \u00d7 HCl (0.550 mmol) and 0.077 cm3 TEA (0.55 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (100:1, 50:1, 20:1 v/v) to give pure compound 20b (0.141 g, 74% yield) as a white powder. M.p.: 196\u2013197 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3229, 3161, 3035, 2979, 2930, 2827, 1695, 1651, 1230, 1022 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 7.35 (s, 1H, HC6), 4.37 (s, 2H, C(O)CH2), 4.16\u20134.07 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.45 (dt, J = 12.2 Hz, J = 7.6 Hz, 2H, PCH2CH\n2), 2.07 (dt, J = 18.2 Hz, J = 7.6 Hz, 2H, PCH\n2), 1.88 (s, 3H, CH3), 1.34 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.10, 165.57, 151.65, 142.24, 109.71, 62.10 (d, J = 6.5 Hz, POC), 49.68, 33.39 (d, J = 1.5 Hz), 24.88 (d, J = 138.9 Hz, PC), 15.34 (d, J = 6.0 Hz, POCC), 10.82 ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 33.29 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(3,4-dihydro-5-methyl-2,4-dioxopyrimidin-1(2H)-yl)acetamido]ethylphosphonate (20b, C13H22N3O6P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.050 g diethyl 3-aminopropylphosphonate (7c, 0.26 mmol) and 0.047 g (thymine-1-yl)acetic acid (12, 0.26 mmol) in the presence of 0.049 g EDC \u00d7 HCl (0.26 mmol) and 0.036 cm3 TEA (0.26 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and the selected fractions were crystallized from a methanol\u2013diethyl ether mixture to give pure compound 20c (0.043 g, 46% yield) as a white solid. M.p.: 183\u2013184 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3264, 3158, 3093, 3035, 2982, 2944, 2884, 2830, 1698, 1683, 1238, 1016 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 7.38 (q, J = 1.3 Hz, 1H, HC6), 4.40 (s, 2H, C(O)CH2), 4.16\u20134.07 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.30 (t, J = 6.9 Hz, 2H, PCH2CH2CH\n2), 1.90 (d, J = 1.3 Hz, 3H, CH3), 1.88\u20131.77 (m, 4H, PCH\n2CH\n2), 1.35 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.26, 165.61, 151.62, 142.25, 109.65, 61.87 (d, J = 6.6 Hz, POC), 49.84, 39.34 (d, J = 18.1 Hz, PCCC), 22.13 (d, J = 4.7 Hz, PCC), 21.92 (d, J = 141.9 Hz, PC), 15.30 (d, J = 6.2 Hz, POCC), 10.78 ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 32.78 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(3,4-dihydro-5-methyl-2,4-dioxopyrimidin-1(2H)-yl)acetamido]propylphosphonate (20c, C14H24N3O6P\u00a0\u00d7\u00a00.5H2O) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.072 g diethyl (2-aminoethoxy)methylphosphonate (7d, 0.34 mmol) and 0.063 g (thymine-1-yl)acetic acid (12, 0.34 mmol) in the presence of 0.065 g EDC \u00d7 HCl (0.34 mmol) and 0.048 cm3 TEA (0.34 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and the selected fractions were crystallized from ethyl acetate to give pure compound 20d (0.060 g, 47% yield) as a white solid. M.p.: 116\u2013117 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3323, 3151, 3078, 3057, 2982, 2954, 2906, 2837, 1678, 1661, 1236, 1026 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 7.40 (q, J = 1.1 Hz, 1H, HC6), 4.44 (s, 2H, C(O)CH2), 4.29\u20134.14 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.93 (d, J = 8.5 Hz, 2H, PCH2O), 3.69 (t, J = 5.3 Hz, 2H, PCH2OCH\n2CH2), 3.46 (t, J = 5.3 Hz, 2H, PCOCH2CH\n2), 1.92 (d, J = 1.1 Hz, 3H, CH3), 1.38 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.23, 165.60, 151.62, 142.26, 109.62, 71.45 (d, J = 12.1 Hz, PCOC), 64.17 (d, J = 167.6 Hz, PC), 62.78 (d, J = 6.7 Hz, POC), 49.54, 38.98, 15.37 (d, J = 5.6 Hz, POCC), 10.79 ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 23.10 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(3,4-dihydro-5-methyl-2,4-dioxopyrimidin-1(2H)-yl)acetamido)ethoxy]methylphosphonate (20d, C14H24N3O7P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.104 g diethyl aminomethylphosphonate (7a, 0.622 mmol) and 0.189 g [N\n4-[(benzyloxy)carbonyl]cytosine-1-yl]acetic acid (13, 0.622 mmol) in the presence of 0.119 g EDC \u00d7 HCl (0.622 mmol) and 0.087 cm3 TEA (0.62 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (100:1, 50:1, 20:1 v/v) and the selected fractions were crystallized from a methanol\u2013petroleum ether mixture to give pure compound 21a (0.125 g, 44% yield) as a white solid. M.p.: 180\u2013182 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3279, 3147, 3081, 2990, 2949, 2928, 1753, 1657, 1257, 1205, 1025 cm\u22121; 1H NMR (600 MHz, CDCl3): \u03b4 = 9.18 (brs, 1H, HNCbz), 8.29 (brt, J = 5.9 Hz, 1H, HNC(O)), 7.66 (d, J = 7.1 Hz, 1H, HC6), 7.41\u20137.29 (m, 5H), 7.25 (brs, 1H), 5.22 (s, 2H, CH\n2C6H5), 4.65 (s, 2H, C(O)CH2), 4.12\u20134.07 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.75 (dd, J = 11.8 Hz, J = 5.9 Hz, 2H, PCH2), 1.28 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CDCl3): \u03b4 = 166.89 (d, J = 4.6 Hz), 163.24, 156.18, 152.72, 149.37, 135.32, 128.61, 128.50, 128.19, 95.55, 67.70, 62.78 (d, J = 6.6 Hz, POC), 52.31, 35.07 (d, J = 157.5 Hz, PC), 16.34 (d, J = 5.6 Hz, POCC) ppm; 31P NMR (273 MHz, CDCl3): \u03b4 = 22.49 ppm.",
            "cite_spans": [],
            "section": "Diethyl [2-[4-[[(benzyloxy)carbonyl]amino]-2-oxopyrimidin-1(2H)-yl]acetamido]methylphosphonate (21a, C19H25N4O7P\u00a0\u00d7\u00a00.5H2O) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.111 g diethyl 2-aminoethylphosphonate (7b, 0.613 mmol) and 0.186 g [N\n4-[(benzyloxy)carbonyl]cytosine-1-yl]acetic acid (13, 0.613 mmol) in the presence of 0.117 g EDC \u00d7 HCl (0.613 mmol) and 0.085 cm3 TEA (0.61 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (100:1, 50:1, 20:1 v/v) to give pure compound 21b (0.224 g, 78% yield) as a white solid. M.p.: 127\u2013128 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3241, 3063, 3035, 2982, 2930, 1742, 1657, 1630, 1215, 1056 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 7.92 (d, J = 7.3 Hz, 1H, HC6), 7.44\u20137.33 (m, 5H), 7.30 (d, J = 7.3 Hz, 1H, HC5), 5.25 (s, 2H, CH\n2C6H5), 4.56 (s, 2H, C(O)CH2), 4.18\u20134.08 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.48 (dt, J = 11.7 Hz, J = 7.6 Hz, 2H, PCH2CH\n2), 2.11 (dt, J = 18.2 Hz, J = 7.6 Hz, 2H, PCH\n2), 1.35 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.65, 164.11, 157.08, 153.17, 150.21, 135.80, 128.23, 128.06, 127.89, 95.39, 67.21, 62.08 (d, J = 6.5 Hz, POC), 51.96, 33.47, 24.89 (d, J = 139.5 Hz, PC), 15.34 (d, J = 5.6 Hz, POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 29.35 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-[4-[[(benzyloxy)carbonyl]amino]-2-oxopyrimidin-1(2H)-yl]acetamido]ethylphosphonate (21b, C20H27N4O7P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.050 g diethyl 3-aminopropylphosphonate (7c, 0.26 mmol) and 0.078 g [N\n4-[(benzyloxy)carbonyl]cytosine-1-yl]acetic acid (13, 0.26 mmol) in the presence of 0.049 g EDC \u00d7 HCl (0.26 mmol) and 0.036 cm3 TEA (0.26 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and the selected fractions were crystallized from an ethyl acetate\u2013hexane mixture to give pure compound 21c (0.066 g, 54% yield) as white needles. M.p.: 150\u2013151 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3281, 3239, 3149, 3089, 3038, 2976, 2939, 1749, 1687, 1653, 1225, 1021 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 7.93 (d, J = 7.3 Hz, 1H, HC6), 7.45\u20137.35 (m, 5H), 7.31 (d, J = 7.3 Hz, 1H, HC5), 5.25 (s, 2H, CH\n2C6H5), 4.56 (s, 2H, C(O)CH2), 4.16\u20134.07 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.32 (t, J = 6.5 Hz, 2H, PCH2CH2CH\n2), 1.90\u20131.78 (m, 4H, PCH\n2CH\n2), 1.34 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.79, 163.99, 157.04, 153.17, 150.28, 135.82, 128.23, 128.06, 127.89, 95.31, 67.20, 61.88 (d, J = 6.6 Hz, POC), 52.08, 39.43 (d, J = 18.7 Hz, PCCC), 22.12 (d, J = 4.9 Hz, PCC), 21.95 (d, J = 141.9 Hz, PC), 15.36 (d, J = 5.9 Hz, POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 32.77 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-[4-[[(benzyloxy)carbonyl]amino]-2-oxopyrimidin-1(2H)-yl]acetamido]propylphosphonate (21c, C21H29N4O7P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.068 g diethyl (2-aminoethoxy)methylphosphonate (7d, 0.32 mmol) and 0.098 g [N\n4-[(benzyloxy)carbonyl]cytosine-1-yl]acetic acid (13, 0.32 mmol) in the presence of 0.062 g EDC \u00d7 HCl (0.32 mmol) and 0.045 cm3 TEA (0.32 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and the selected fractions were crystallized from an ethyl acetate\u2013hexane mixture to give pure compound 21d (0.073 g, 48% yield) as a white solid. M.p.: 129\u2013131 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3332, 3145, 3069, 3032, 2981, 2930, 2869, 1751, 1658, 1214, 1022 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 7.96 (d, J = 7.4 Hz, 1H, HC6), 7.50\u20137.34 (m, 5H), 7.34 (d, J = 7.4 Hz, 1H, HC5), 5.27 (s, 2H, CH\n2C6H5), 4.61 (s, 2H, C(O)CH2), 4.28\u20134.14 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.93 (d, J = 8.5 Hz, 2H, PCH2O), 3.69 (t, J = 5.3 Hz, 2H, PCH2OCH\n2CH2), 3.46 (t, J = 5.3 Hz, 2H, PCOCH2CH\n2), 1.38 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.77, 163.97, 157.06, 153.17, 150.26, 135.82, 128.23, 128.06, 127.89, 95.29, 71.48 (d, J = 12.0 Hz, PCOC), 67.21, 64.21 (d, J = 166.1 Hz, PC), 62.79 (d, J = 6.6 Hz, POC), 51.82, 39.00, 15.41 (d, J = 5.8 Hz, POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 23.10 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-[4-[[(benzyloxy)carbonyl]amino]-2-oxopyrimidin-1(2H)-yl]acetamido] ethoxy]methylphosphonate (21d, C21H29N4O8P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.058 g diethyl aminomethylphosphonate (7a, 0.35 mmol) and 0.076 g 2-(3,4-dihydro-2,4-dioxoquinazolin-1-yl)acetic acid (14, 0.35 mmol) in the presence of 0.067 g EDC \u00d7 HCl (0.35 mmol) and 0.048 cm3 TEA (0.35 mmol) according to the general procedure C was chromatographed with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and the selected fractions were crystallized from a methanol\u2013diethyl ether mixture to give pure compound 22a (0.086 g, 67% yield) as a white powder. M.p.: 203\u2013205 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3462, 3264, 3197, 2975, 2909, 1736, 1638, 1044, 1013 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 8.10\u20138.05 (m, 1H), 7.75\u20137.66 (m, 1H), 7.32-7.21 (m, 2H), 4.76 (d, J = 1.6 Hz, 2H, C(O)CH2), 4.27\u20134.12 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.78 (d, J = 11.8 Hz, 2H, PCH2), 1.37 (t, J = 6.8 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 166.47 (d, J = 4.0 Hz, C(O)NHCP), 162.72, 150.78, 139.58, 135.05, 127.50, 122.72, 114.90, 113.99, 62.86 (d, J = 6.6 Hz, POC), 42.31, 34.23 (d, J = 158.4 Hz, PC), 15.30 (d, J = 5.6 Hz, POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 23.56 ppm.",
            "cite_spans": [],
            "section": "Diethyl [2-(3,4-dihydro-2,4-dioxoquinazolin-1(2H)-yl)acetamido]methylphosphonate (22a, C15H20N3O6P\u00a0\u00d7\u00a02H2O) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.051 g diethyl 2-aminoethylphosphonate (7b, 0.28 mmol) and 0.062 g 2-(3,4-dihydro-2,4-dioxoquinazolin-1-yl)acetic acid (14, 0.28 mmol) in the presence of 0.054 g EDC \u00d7 HCl (0.28 mmol) and 0.039 cm3 TEA (0.28 mmol) according to the general procedure C was chromatographed with chloroform\u2013methanol mixtures (100:1, 50:1, 20:1 v/v) to give pure compound 22b (0.073 g, 68% yield) as a white powder. M.p.: 180\u2013182 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3249, 3205, 3083, 2983, 2930, 2882, 1736, 1637, 1027 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 8.64 (dd, J = 7.1 Hz, J = 1.3 Hz, 1H), 7.69 (dt, 1H, J = 7.1 Hz, J = 1.0 Hz), 7.27 (dt, J = 8.2 Hz, J = 1.0 Hz, 1H), 7.22 (d, J = 8.2 Hz, 1H), 4.69 (s, 2H, C(O)CH2), 4.19\u20134.09 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.50\u20133.46 (m, 2H, PCH2CH\n2), 2.14\u20132.08 (m, 2H, PCH\n2), 1.36 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.55, 162.76, 150.80, 139.55, 135.04, 127.50, 122.73, 114.90, 113.99, 62.06 (d, J = 6.6 Hz, POC), 42.55 (PCC), 33.40, 26.64, 24.91 (d, J = 138.9 Hz, PC), 15.32 (d, J = 6.0 Hz, POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 29.51 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(3,4-dihydro-2,4-dioxoquinazolin-1(2H)-yl)acetamido]ethylphosphonate (22b, C16H22N3O6P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.085 g diethyl 3-aminopropylphosphonate (7c, 0.435 mmol) and 0.096 g 2-(3,4-dihydro-2,4-dioxoquinazolin-1-yl)acetic acid (14, 0.435 mmol) in the presence of 0.083 g EDC \u00d7 HCl (0.435 mmol) and 0.061 cm3 TEA (0.435 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) to give pure compound 22c (0.083 g, 48% yield) as a white powder. M.p.: 168\u2013169 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3267, 3201, 3148, 3065, 2984, 2928, 1736, 1661, 1638, 1232, 1031 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 8.07\u20138.02 (m, 1H), 7.73\u20137.64 (m, 1H), 7.30\u20137.17 (m, 2H), 4.70 (s, 2H, C(O)CH2), 4.23\u20134.05 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.33 (t, J = 6.5 Hz, 2H, PCH2CH2CH\n2), 1.98\u20131.67 (m, 4H, PCH\n2CH\n2), 1.36 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.74, 162.82, 150.84, 139.61, 135.01, 127.50, 122.68, 114.88, 114.07, 61.86 (d, J = 6.6 Hz, POC), 42.60, 39.24 (d, J = 19.0 Hz, PCCC), 22.17 (d, J = 4.5 Hz, PCC), 21.85 (d, J = 141.9 Hz, PC), 15.30 (d, J = 6.3 Hz, POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 33.86 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(3,4-dihydro-2,4-dioxoquinazolin-1(2H)-yl)acetamido]propylphosphonate (22c, C17H24N3O6P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.078 g diethyl (2-aminoethoxy)methylphosphonate (7d, 0.37 mmol) and 0.061 g 2-(3,4-dihydro-2,4-dioxoquinazolin-1-yl)acetic acid (14, 0.37 mmol) in the presence of 0.071 g EDC \u00d7 HCl (0.37 mmol) and 0.051 cm3 TEA (0.37 mmol) according to the general procedure C was chromatographed with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) to give pure compound 22d (0.127 g, 83% yield) as a white solid. M.p.: 169\u2013170 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3196, 3148, 3123, 3065, 2978, 2940, 1737, 1639, 1240, 1028 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 8.09\u20138.04 (m, 1H), 7.74-7.66 (m, 1H), 7.32\u20137.21 (m, 2H), 4.72 (s, 2H, C(O)CH2), 4.29\u20134.14 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.94 (d, J = 8.5 Hz, 2H, PCH2O), 3.70 (t, J = 5.3 Hz, 2H, PCH2OCH\n2CH2), 3.46 (t, J = 5.3 Hz, 2H, PCOCH2CH\n2), 1.38 (t, J = 7.0 Hz, 3H, POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 168.64, 162.78, 150.82, 139.58, 135.00, 127.50, 122.69, 114.89, 114.04, 71.55 (d, J = 12.1 Hz, PCOC), 64.25 (d, J = 166.3 Hz, PC), 62.84 (d, J = 6.6 Hz, POC), 42.47, 39.00, 15.39 (d, J = 5.6 Hz, POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 23.08 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(3,4-dihydro-2,4-dioxoquinazolin-1(2H)-yl)acetamido]ethoxy]methylphosphonate (22d, C17H24N3O7P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.109 g diethyl aminomethylphosphonate (7a, 0.622 mmol) and 0.256 g 2-[6-[bis(tert-butoxycarbonyl)amino]-9H-purin-9-yl]acetic acid (15, 0.622 mmol) in the presence of 0.125 g EDC \u00d7 HCl (0.622 mmol) and 0.091 cm3 TEA (0.62 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (100:1, 50:1, 20:1 v/v) and the selected fractions were crystallized from a methanol\u2013petroleum ether mixture to give pure compound 23a (0.183 g, 52% yield) as a white solid. M.p.: 128\u2013130 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3256, 3109, 2980, 2934, 1735, 1699, 1672, 1049 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 8.85 (s, 1H), 8.54 (s, 1H), 5.19 (s, 2H, C(O)CH2), 4.19\u20134.14 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.78 (d, J = 11.8 Hz, 2H, PCH2), 1.41 (s, 18H, 6 \u00d7 CH3), 1.33 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 166.75 (d, J = 4.4 Hz, C(O)NHCP), 153.84, 151.66, 150.14, 149.47, 147.72, 128.37, 83.91, 62.81 (d, J = 6.5 Hz, POC), 45.14, 34.41 (d, J = 158.6 Hz, PC), 26.65, 15.36 (d, J = 5.7 Hz, POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 22.68 ppm.",
            "cite_spans": [],
            "section": "Diethyl [2-[6-(bis(tert-butoxycarbonyl))amino-9H-purin-9-yl]acetamido]methylphosphonate (23a, C22H35N6O8P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.108 g diethyl 2-aminoethylphosphonate (7b, 0.596 mmol) and 0.235 g 2-[6-[bis(tert-butoxycarbonyl)amino]-9H-purin-9-yl]acetic acid (15, 0.596 mmol) in the presence of 0.114 g EDC \u00d7 HCl (0.596 mmol) and 0.083 cm3 TEA (0.60 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (100:1, 50:1, 20:1 v/v) to give pure compound 23b (0.155 g, 47% yield) as a colorless oil. IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3356, 3284, 3085, 2983, 2936, 1788, 1760, 1697, 1251, 1027 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 8.87 (s, 1H), 8.56 (s, 1H), 5.14 (s, 2H, C(O)CH2), 4.25\u20134.07 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.60\u20133.48 (m, 2H, PCH2CH\n2), 2.22\u20132.06 (m, 2H, 2H, PCH\n2), 1.43 (s, 18H, 6 \u00d7 CH3), 1.37 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 166.73, 153.85, 151.65, 150.17, 149.46, 147.72, 128.37, 83.91, 62.08 (d, J = 6.6 Hz, POC), 45.26, 33.57, 26.64, 24.89 (d, J = 138.9 Hz, PC), 15.37 (d, J = 5.7 Hz, POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 30.17 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-[6-(bis(tert-butoxycarbonyl))amino-9H-purin-9-yl]acetamido]ethylphosphonate (23b, C23H37N6O8P\u00a0\u00d7\u00a00.5 H2O) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.059 g diethyl 3-aminopropylphosphonate (15, 0.30 mmol) and 0.119 g 2-[6-[bis(tert-butoxycarbonyl)amino]-9H-purin-9-yl]acetic acid (15, 0.302 mmol) in the presence of 0.058 g EDC \u00d7 HCl (0.30 mmol) and 0.042 cm3 TEA (0.30 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (100:1 v/v) to give pure compound 23c (0.072 g, 42% yield) as an yellowish oil. IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3363, 3281, 3087, 2983, 2937, 1788, 1693, 1220, 1024 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 8.85 (s, 1H), 8.53 (s, 1H), 5.12 (s, 2H, C(O)CH2), 4.17\u20134.07 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.36 (t, J = 6.5 Hz, 2H, PCH2CH2CH\n2), 1.92\u20131.78 (m, 4H, PCH\n2CH\n2), 1.42 (s, 18H, 6 \u00d7 CH3), 1.34 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 166.90, 153.82, 151.65, 150.16, 149.46, 147.73, 128.43, 83.92, 61.88 (d, J = 6.6 Hz, POC), 45.42, 39.50 (d, J = 19.6 Hz, PCCC), 26.61, 22.14 (d, J = 4.6 Hz, PCC), 22.00 (d, J = 142.6 Hz, PC), 15.33 (d, J = 5.6 Hz, POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 32.68 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-[6-(bis(tert-butoxycarbonyl))amino-9H-purin-9-yl]acetamido]propylphosphonate (23c, C24H39N6O8P\u00a0\u00d7\u00a00.5H2O) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.070 g diethyl (2-aminoethoxy)methylphosphonate (7d, 0.33 mmol) and 0.130 g 2-[6-[bis(tert-butoxycarbonyl)amino]-9H-purin-9-yl]acetic acid (15, 0.33 mmol) in the presence of 0.064 g EDC \u00d7 HCl (0.33 mmol) and 0.046 cm3 TEA (0.33 mmol) according to the general procedure B was chromatographed with chloroform\u2013methanol mixtures (100:1, 50:1 v/v) to give pure compound 23d (0.102 g, 52% yield) as a colorless oil. IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3282, 3086, 2982, 2935, 1786, 1757, 1220, 1028 cm\u22121; 1H NMR (200 MHz, CDCl3): \u03b4 = 8.83 (s, 1H), 8.26 (s, 1H), 7.69 (t, J = 6.0 Hz, 1H, C(O)NHCH2), 4.96 (s, 2H, C(O)CH2), 4.29\u20134.10 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.82 (d, J = 7.9 Hz, 2H, PCH2O), 3.70 (t, J = 4.6 Hz, 2H, PCH2OCH\n2CH2), 3.50 (t, J = 4.6 Hz, 2H, PCOCH2CH\n2), 1.43 (s, 18 H, 6 \u00d7 CH3), 1.35 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CDCl3): \u03b4 = 165.64, 153.53, 152.02, 150.43, 150.34, 145.63, 128.44, 83.72, 72.22 (d, J = 8.8 Hz, PCOC), 65.59 (d, J = 166.8 Hz, PC), 62.69 (d, J = 6.7 Hz, POC), 46.07, 39.76, 27.79, 16.46 (d, J = 5.5 Hz, POCC) ppm; 31P NMR (81 MHz, CDCl3): \u03b4 = 22.77 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-[6-(bis(tert-butoxycarbonyl))amino-9H-purin-9-yl]acetamido]ethoxy)methyl)phosphonate (23d, C24H39N6O9P\u00a0\u00d7\u00a00.5H2O) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.419 g diethyl aminomethylphosphonate (7a, 2.51 mmol) and 0.571 g 2-(2-amino-6-chloropurin-9-yl)acetic acid (16, 2.51 mmol) in the presence of 0.481 g EDC \u00d7 HCl (2.51 mmol) and 0.358 cm3 TEA (2.51 mmol) according to the general procedure C was chromatographed with chloroform\u2013methanol mixtures (50:1, 20:1 v/v) and the selected fractions were crystallized from a methanol\u2013diethyl ether mixture to give pure compound 24a (0.211 g, 22% yield) as a white solid. M.p.: 130\u2013132 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3397, 3340, 3221, 3111, 3065, 2987, 2946, 1684, 1610, 1562, 1219, 1053, 1013 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 8.11 (s, 1H), 4.95 (d, J = 1.4 Hz, 2H, C(O)CH2), 4.21\u20134.10 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.78 (d, J = 11.8 Hz, 2H, PCH2), 1.34 (t, J = 7.0 Hz, 3H, POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.18 (d, J = 3.5 Hz), 160.32, 154.18, 150.17, 143.84, 123.22, 62.80 (d, J = 6.6 Hz, POC), 44.82, 34.37 (d, J = 158.6 Hz, PC), 15.26 (d, J = 6.0 Hz, POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 23.56 ppm.",
            "cite_spans": [],
            "section": "Diethyl [2-(2-amino-6-chloro-9H-purin-9-yl)acetamido]methylphosphonate (24a, C12H18ClN6O4P\u00a0\u00d7\u00a00.5H2O) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.307 g diethyl 2-aminoethylphosphonate (7b, 1.69 mmol) and 0.386 g 2-(2-amino-6-chloropurin-9-yl)acetic acid (16, 1.69 mmol) in the presence of 0.325 g EDC \u00d7 HCl (1.69 mmol) and 0.236 cm3 TEA (1.69 mmol) according to the general procedure C was chromatographed with chloroform\u2013methanol mixtures (50:1, 30:1, 10:1 v/v) and the selected fractions were crystallized from a methanol\u2013diethyl ether mixture to give pure compound 24b (0.126 g, 19% yield) as a white solid. M.p.: 158\u2013160 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3411, 3322, 3275, 3122, 3074, 2985, 2929, 1688, 1254, 1030 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 8.05 (s, 1H), 4.84 (s, 2H, C(O)CH2), 4.13\u20134.09 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.48-3.44 (m, 2H, PCH2CH\n2), 2.10\u20132.06 (m, 2H, 2H, PCH\n2), 1.32 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 171.14, 164.26, 158.13, 154.12, 147.78, 127.21, 66.02 (d, J = 6.0 Hz, POC), 48.96, 37.43 (d, J = 1.7 Hz), 28.80 (d, J = 138.9 Hz, PC), 19.24 (d, J = 6.1 Hz, POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 33.23 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(2-amino-6-chloro-9H-purin-9-yl)acetamido]ethylphosphonate (24b, C13H20ClN6O4P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.203 g diethyl 3-aminopropylphosphonate (7c, 1.04 mmol) and 0.237 g 2-(2-amino-6-chloropurin-9-yl)acetic acid (16, 1.04 mmol) in the presence of 0.199 g EDC \u00d7 HCl (1.04 mmol) and 0.145 cm3 TEA (1.04 mmol) according to the general procedure C was chromatographed with dichloromethane\u2013methanol mixtures (50:1, 20:1, 10:1 v/v) and the selected fractions were crystallized from an ethanol\u2013ethyl acetate mixture to give pure compound 24c (0.106 g, 25% yield) as a white solid. M.p.: 180\u2013181 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3408, 3343, 3273, 3090, 2988, 2945, 2908, 2869, 1680, 1644, 1608, 1215, 1040 cm\u22121; 1H NMR (600 MHz, CD3OD): \u03b4 = 8.07 (s, 1H), 4.87 (s, 2H, C(O)CH2), 4.15\u20134.06 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.33 (t, J = 6.5 Hz, 2H, PCH2CH2CH\n2), 1.88\u20131.77 (m, 4H, PCH\n2CH\n2), 1.33 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.34, 160.31, 154.19, 150.17, 143.87, 123.32, 61.90 (d, J = 6.7 Hz, POC), 45.15, 39.41 (d, J = 19.6 Hz, PCCC), 26.61, 22.11 (d, J = 4.9 Hz, PCC), 21.98 (d, J = 142.1 Hz, PC), 15.30 (d, J = 6.0 Hz, POCC) ppm; 31P NMR (243 MHz, CD3OD): \u03b4 = 32.75 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(2-amino-6-chloro-9H-purin-9-yl)acetamido]propylphosphonate (24c, C24H39N6O8P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The crude product obtained from 0.200 g diethyl (2-aminoethoxy)methylphosphonate (7d, 0.947 mmol) and 0.216 g 2-(2-amino-6-chloropurin-9-yl)acetic acid (16, 0.947 mmol) in the presence of 0.182 g EDC \u00d7 HCl (0.947 mmol) and 0.132 cm3 TEA (0.947 mmol) according to the general procedure C was chromatographed with chloroform\u2013methanol mixtures (50:1, 30:1 v/v) and the selected fractions were crystallized from an ethyl acetate\u2013hexane mixture to give pure compound 24d (0.048 g, 15% yield) as a white solid. M.p.: 91\u201393 \u00b0C; IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3430, 3335, 3220, 3095, 2981, 2938, 1650, 1611, 1245, 1024, 910 cm\u22121; 1H NMR (200 MHz, CD3OD): \u03b4 = 8.10 (s, 1H), 4.92 (s, 2H, C(O)CH2; superimposed in the HOD signal), 4.28\u20134.13 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.92 (d, J = 8.6 Hz, 2H, PCH2O), 3.70 (t, J = 5.3 Hz, 2H, PCH2OCH\n2CH2), 3.47 (t, J = 5.3 Hz, 2H, PCOCH2CH\n2), 1.37 (t, J = 7.1 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, CD3OD): \u03b4 = 167.33, 160.30, 154.21, 150.14, 143.92, 123.25, 71.42 (d, J = 12.1 Hz, PCOC), 64.18 (d, J = 167.6 Hz, PC), 62.77 (d, J = 6.6 Hz, POC), 44.96, 39.04, 15.36 (d, J = 5.5 Hz, POCC) ppm; 31P NMR (81 MHz, CD3OD): \u03b4 = 23.11 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(2-amino-6-chloro-9H-purin-9-yl)acetamido]ethoxy)methyl)phosphonate (24d, C14H22ClN6O5P) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "A mixture of phosphonates 24a\u201324d (1.00 mmol) and 8 cm3 of a 75% aqueous trifluoroacetic acid was stirred at room temperature for 48 h, concentrated in vacuo and co-evaporated with water (3 \u00d7 5 cm3), ethanol (3 \u00d7 5 cm3), and chloroform (3 \u00d7 5 cm3). The residue was crystallized from the appropriate solvent.",
            "cite_spans": [],
            "section": "Synthesis of the guanine derivatives 25a\u201325d (general procedure) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "From 0.112 g of compound 24a (0.297 mmol) the phosphonate 25a (0.087 g, 81%) was obtained as a white solid after crystallization from a methanol\u2013diethyl ether mixture. M.p.: 165 \u00b0C (decomposition); IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3425, 2988, 2928, 2854, 2732, 1697, 1214, 1026 cm\u22121; 1H NMR (600 MHz, DMSO-d\n6): \u03b4 = 10.63 (s, 1H, NH), 8.61 (t, J = 5.9 Hz, 1H, C(O)NHCH2), 7.73 (s, 1H), 6.47 (s, 2H, NH2), 4.72 (s, 2H, C(O)CH2), 4.06\u20133.98 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.60 (dd, J = 11.8 Hz, J = 5.9 Hz, 2H, PCH2), 1.24 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, DMSO-d\n6): \u03b4 = 166.96 (d, J = 4.5 Hz), 156.98, 154.22, 151.84, 138.76, 115.84, 62.35 (d, J = 6.0 Hz, POC), 45.24, 34.69 (d, J = 154.0 Hz, PC), 16.70 (d, J = 6.0 Hz, POCC) ppm; 31P NMR (243 MHz, DMSO-d\n6): \u03b4 = 22.46 ppm.",
            "cite_spans": [],
            "section": "Diethyl [2-(2-amino-1,6-dihydro-6-oxopurin-9-yl)acetamido]methylphosphonate (25a, C12H19N6O5P\u00a0\u00d7\u00a02.5H2O) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "From 0.127 g of compound 24b (0.325 mmol) the phosphonate 25a (0.109 g, 90%) was obtained as a white solid after crystallization from a methanol\u2013diethyl ether mixture. M.p.: 175 \u00b0C (decomposition); IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3383, 2925, 2854, 1688, 1606, 1220, 1026 cm\u22121; 1H NMR (600 MHz, DMSO-d\n6): \u03b4 = 10.73 (s, 1H, NH), 8.35 (t, J = 5.5 Hz, 1H, C(O)NHCH2), 7.73 (s, 1H), 6.58 (s, 2H, NH2), 4.63 (s, 2H, C(O)CH2), 4.03\u20133.95 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.30-3.24 (m, 2H, PCH2CH\n2), 1.98\u20131.91 (m, 2H, 2H, PCH\n2), 1.24 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, DMSO-d\n6): \u03b4 = 166.78, 157.00, 154.31, 151.82, 138.68, 116.03, 61.62 (d, J = 4.5 Hz, POC), 45.45, 33.77, 25.72 (d, J = 136.2 Hz, PC), 16.71 (d, J = 5.7 Hz, POCC) ppm; 31P NMR (81 MHz, DMSO-d\n6): \u03b4 = 30.12 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(2-amino-1,6-dihydro-6-oxopurin-9-yl)acetamido]ethylphosphonate (25b, C13H21N6O5P\u00a0\u00d7\u00a0H2O) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "From 0.050 g of compound 24c (0.12 mmol) the phosphonate 25c (0.042 g, 87%) was obtained as a white solid after crystallization from a methanol\u2013diethyl ether\u2013petroleum ether mixture. M.p.: 155 \u00b0C (decomposition); IR (KBr): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3385, 3277, 2928, 2864, 1689, 1609, 1228, 1020 cm\u22121; 1H NMR (600 MHz, DMSO-d\n6): \u03b4 = 10.91 (s, 1H, NH), 8.29 (t, J = 5.5 Hz, 1H, C(O)NHCH2), 8.06 (s, 1H), 6.68 (s, 2H, NH2), 4.70 (s, 2H, C(O)CH2), 4.04-3.95 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.33 (dd, J = 12.7 Hz, J = 6.5 Hz, 2H, PCH2CH2CH\n2), 1.79\u20131.70 (m, 2H, PCH2CH\n2), 1.67\u20131.58 (m, 2H, PCH\n2CH2), 1.24 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, DMSO-d\n6): \u03b4 = 166.36, 156.24, 154.69, 151.53, 138.77, 113.98, 61.42 (d, J = 6.4 Hz, POC), 45.74, 39.62 (d, J = 18.3 Hz, PCCC), 22.80 (d, J = 4.5 Hz, PCC), 22.65 (d, J = 140.4 Hz, PC), 16.74 (d, J = 4.5 Hz, POCC) ppm; 31P NMR (243 MHz, DMSO-d\n6): \u03b4 = 31.64 ppm.",
            "cite_spans": [],
            "section": "Diethyl 3-[2-(2-amino-1,6-dihydro-6-oxopurin-9-yl)acetamido]propylphosphonate (25c, C14H23N6O5P\u00a0\u00d7\u00a02H2O) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "From 0.012 g of compound 24d (0.029 mmol) the phosphonate 25d (0.010 g, 83%) was obtained as a yellowish oil. IR (film): \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\bar{\\nu }$$\\end{document}\u03bd\u00af = 3378, 3288, 2938, 2881, 1690, 1611, 1225, 1018 cm\u22121; 1H NMR (600 MHz, DMSO-d\n6): \u03b4 = 10.64 (s, 1H), 8.28 (t, J = 5.6 Hz, 1H), 7.80 (brs, 1H), 6.50 (s, 2H), 4.66 (s, 2H, C(O)CH2), 4.08\u20134.03 (m, 4H, 2 \u00d7 POCH\n2CH3), 3.83 (d, J = 8.0 Hz, 2H, PCH2O), 3.56 (t, J = 5.7 Hz, 2H, PCH2OCH\n2CH2), 3.27 (q, J = 5.7 Hz, 2H, PCOCH2CH\n2), 1.25 (t, J = 7.0 Hz, 6H, 2 \u00d7 POCH2CH\n3) ppm; 13C NMR (151 MHz, DMSO-d\n6): \u03b4 = 166.87, 156.96, 154.28, 150.14, 138.78, 115.52, 71.44 (d, J = 11.0 Hz, PCOC), 64.50 (d, J = 162.9 Hz, PC), 62.23 (d, J = 6.3 Hz, POC), 45.44, 39.02, 16.75 (d, J = 5.2 Hz, POCC) ppm; 31P NMR (243 MHz, DMSO-d\n6): \u03b4 = 21.45 ppm.",
            "cite_spans": [],
            "section": "Diethyl 2-[2-(2-amino-1,6-dihydro-6-oxopurin-9-yl)acetamido]ethoxy)methyl)phosphonate (25d, C14H23N6O6P\u00a0\u00d7\u00a0H2O) ::: General procedure C ::: Synthesis of amides 17\u201324 ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "The compounds were evaluated against the following viruses: herpes simplex virus type 1 (HSV-1) strain KOS, herpes simplex virus-2 strain G, thymidine kinase-deficient (TK\u2212) HSV-1 KOS strain resistant to ACV (ACVr), adenovirus-2, vesicular stomatitis virus, varicella-zoster virus (VZV) strain Oka, TK\u2212 VZV strain 07-1, human cytomegalovirus (HCMV) strains AD-169 and Davis, feline herpes virus (FHV), vaccinia virus Lederle strain, respiratory syncytial virus (RSV) strain Long, vesicular stomatitis virus (VSV), feline coronovirus (FIPV), Coxsackie B4, Parainfluenza 3, Influenza virus A (subtypes H1N1, H3N2), influenza virus B, Reovirus-1, Sindbis, Reovirus-1, Punta Toro, yellow fever virus. The antiviral, other than anti-HIV, assays were based on inhibition of virus-induced cytopathicity or plaque formation in human embryonic lung (HEL) fibroblasts, African green monkey cells (Vero), human epithelial cells (HeLa), Crandell\u2013Rees feline kidney cells (CRFK) or Madin\u2013Darby canine kidney cells (MDCK). Confluent cell cultures in microtiter 96-well plates were inoculated with 100 CCID50 of virus (1 CCID50 being the virus dose to infect 50% of the cell cultures) or with 20 plaque forming units (PFU) (VZV) in the presence of varying concentrations of the test compounds. Viral cytopathicity or plaque formation was recorded as soon as it reached completion in the control virus-infected cell cultures that were not treated with the test compounds. Antiviral activity was expressed as the EC50 or compound concentration required to reduce virus-induced cytopathogenicity or viral plaque formation by 50%. Cytotoxicity of the test compounds was expressed as the minimum cytotoxic concentration (MCC) or the compound concentration that caused a microscopically detectable alteration of cell morphology.",
            "cite_spans": [],
            "section": "Antiviral activity assays ::: Experimental",
            "ref_spans": []
        },
        {
            "text": "All assays were performed in 96-well microtiter plates. To each well were added (5\u20137.5) \u00d7 104 tumor cells and a given amount of the test compound. The cells were allowed to proliferate for 48 h (murine leukemia L1210 cells) or 72 h (human lymphocytic CEM and human cervix carcinoma HeLa cells) at 37 \u00b0C in a humidified CO2-controlled atmosphere. At the end of the incubation period, the cells were counted in a Coulter counter. The IC50 (50% inhibitory concentration) was defined as the concentration of the compound that inhibited cell proliferation by 50%.",
            "cite_spans": [],
            "section": "Cytostatic activity assays ::: Experimental",
            "ref_spans": []
        }
    ],
    "ref_entries": {
        "TABREF0": {
            "text": "Table\u00a01: Optimization of the reaction conditions\n",
            "type": "table"
        },
        "FIGREF0": {
            "text": "Fig.\u00a01: Acyclic nucleotide analogs 1\u20134\n",
            "type": "figure"
        },
        "FIGREF1": {
            "text": "Fig.\u00a02: Conformations of phosphonates discussed in this paper",
            "type": "figure"
        },
        "FIGREF2": {
            "text": "Fig.\u00a03: Active derivatives of 5-fluorouracil",
            "type": "figure"
        }
    },
    "back_matter": [],
    "bib_entries": {
        "BIBREF0": {
            "title": "",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Clercq",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Biochem Pharmacol",
            "volume": "73",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.bcp.2006.09.014"
                ]
            }
        },
        "BIBREF1": {
            "title": "",
            "authors": [
                {
                    "first": "AC",
                    "middle": [],
                    "last": "van der Laan",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Havenaar",
                    "suffix": ""
                },
                {
                    "first": "RS",
                    "middle": [],
                    "last": "Oosting",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Kuyl-Yeheskiely",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Uhlmann",
                    "suffix": ""
                },
                {
                    "first": "JH",
                    "middle": [],
                    "last": "van Boom",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Bioorg Med Chem Lett",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S0960-894X(98)00088-2"
                ]
            }
        },
        "BIBREF2": {
            "title": "",
            "authors": [
                {
                    "first": "VA",
                    "middle": [],
                    "last": "Efimov",
                    "suffix": ""
                },
                {
                    "first": "AA",
                    "middle": [],
                    "last": "Buryakova",
                    "suffix": ""
                },
                {
                    "first": "MV",
                    "middle": [],
                    "last": "Choob",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Chakhmakhcheva",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Bioorg Khim",
            "volume": "24",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF3": {
            "title": "",
            "authors": [
                {
                    "first": "FK",
                    "middle": [],
                    "last": "Kalman",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Woods",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Caravan",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Jurek",
                    "suffix": ""
                },
                {
                    "first": "M",
                    "middle": [],
                    "last": "Spiller",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Tircso",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Kiraly",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Bruecher",
                    "suffix": ""
                },
                {
                    "first": "AD",
                    "middle": [],
                    "last": "Sherry",
                    "suffix": ""
                }
            ],
            "year": 2007,
            "venue": "Inorg Chem",
            "volume": "46",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/ic0702926"
                ]
            }
        },
        "BIBREF4": {
            "title": "",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Gali",
                    "suffix": ""
                },
                {
                    "first": "KR",
                    "middle": [],
                    "last": "Prabhu",
                    "suffix": ""
                },
                {
                    "first": "SR",
                    "middle": [],
                    "last": "Karra",
                    "suffix": ""
                },
                {
                    "first": "KV",
                    "middle": [],
                    "last": "Katti",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "J Org Chem",
            "volume": "65",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/jo991067b"
                ]
            }
        },
        "BIBREF5": {
            "title": "",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Koszytkowska-Stawinska",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Clercq",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Balzarini",
                    "suffix": ""
                }
            ],
            "year": 2009,
            "venue": "Bioorg Med Chem",
            "volume": "17",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.bmc.2009.04.054"
                ]
            }
        },
        "BIBREF6": {
            "title": "",
            "authors": [
                {
                    "first": "HL",
                    "middle": [],
                    "last": "Wheeler",
                    "suffix": ""
                },
                {
                    "first": "LM",
                    "middle": [],
                    "last": "Liddle",
                    "suffix": ""
                }
            ],
            "year": 1908,
            "venue": "J Am Chem Soc",
            "volume": "30",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/ja01949a014"
                ]
            }
        },
        "BIBREF7": {
            "title": "",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Tada",
                    "suffix": ""
                }
            ],
            "year": 1975,
            "venue": "Bull Chem Soc Jpn",
            "volume": "48",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1246/bcsj.48.3427"
                ]
            }
        },
        "BIBREF8": {
            "title": "",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "Ferrer",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Shevchenko",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Eritja",
                    "suffix": ""
                }
            ],
            "year": 2000,
            "venue": "Bioorg Med Chem",
            "volume": "8",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S0968-0896(99)00308-9"
                ]
            }
        },
        "BIBREF9": {
            "title": "",
            "authors": [
                {
                    "first": "JL",
                    "middle": [],
                    "last": "Rabinowitz",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Gurin",
                    "suffix": ""
                }
            ],
            "year": 1953,
            "venue": "J Am Chem Soc",
            "volume": "75",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/ja01118a525"
                ]
            }
        },
        "BIBREF10": {
            "title": "",
            "authors": [
                {
                    "first": "P",
                    "middle": [],
                    "last": "Li",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Zhan",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                },
                {
                    "first": "X",
                    "middle": [],
                    "last": "Ding",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Guo",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "He",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Yao",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Tetrahedron",
            "volume": "68",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.tet.2012.08.028"
                ]
            }
        },
        "BIBREF11": {
            "title": "",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Clercq",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Med Res Rev",
            "volume": "33",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1002/med.21274"
                ]
            }
        },
        "BIBREF12": {
            "title": "",
            "authors": [
                {
                    "first": "AR",
                    "middle": [],
                    "last": "Katritzky",
                    "suffix": ""
                },
                {
                    "first": "T",
                    "middle": [],
                    "last": "Narindoshvili",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "Org Biomol Chem",
            "volume": "6",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1039/b806141f"
                ]
            }
        },
        "BIBREF13": {
            "title": "",
            "authors": [
                {
                    "first": "F",
                    "middle": [],
                    "last": "Wojciechowski",
                    "suffix": ""
                },
                {
                    "first": "RHE",
                    "middle": [],
                    "last": "Hudson",
                    "suffix": ""
                }
            ],
            "year": 2008,
            "venue": "J Org Chem",
            "volume": "73",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/jo800195j"
                ]
            }
        },
        "BIBREF14": {
            "title": "",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "Schwergold",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Depecker",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Di Giorgio",
                    "suffix": ""
                },
                {
                    "first": "N",
                    "middle": [],
                    "last": "Patino",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Jossinet",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Ehresmann",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Terreux",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cabrol-Bass",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Condom",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "Tetrahedron",
            "volume": "58",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S0040-4020(02)00527-6"
                ]
            }
        },
        "BIBREF15": {
            "title": "",
            "authors": [
                {
                    "first": "MM",
                    "middle": [],
                    "last": "Joulli\u00e9",
                    "suffix": ""
                },
                {
                    "first": "KM",
                    "middle": [],
                    "last": "Lassen",
                    "suffix": ""
                }
            ],
            "year": 2010,
            "venue": "Arkivoc",
            "volume": "viii",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF16": {
            "title": "",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "El-Faham",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Albericio",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Chem Rev",
            "volume": "111",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/cr100048w"
                ]
            }
        },
        "BIBREF17": {
            "title": "",
            "authors": [
                {
                    "first": "JR",
                    "middle": [],
                    "last": "Dunetz",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Magano",
                    "suffix": ""
                },
                {
                    "first": "GA",
                    "middle": [],
                    "last": "Weisenburger",
                    "suffix": ""
                }
            ],
            "year": 2016,
            "venue": "Org Process Res Dev",
            "volume": "20",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/op500305s"
                ]
            }
        },
        "BIBREF18": {
            "title": "",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Falkiewicz",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "Nucleic Acids Symp Ser",
            "volume": "42",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1093/nass/42.1.153"
                ]
            }
        },
        "BIBREF19": {
            "title": "",
            "authors": [
                {
                    "first": "O",
                    "middle": [],
                    "last": "Noel",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Xie",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Synthesis",
            "volume": "45",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": []
            }
        },
        "BIBREF20": {
            "title": "",
            "authors": [
                {
                    "first": "C",
                    "middle": [],
                    "last": "De Cola",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Manicardi",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Corradini",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Izzo",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "De Riccardis",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Tetrahedron",
            "volume": "68",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.tet.2011.11.017"
                ]
            }
        },
        "BIBREF21": {
            "title": "",
            "authors": [
                {
                    "first": "DS",
                    "middle": [],
                    "last": "MacMillan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Murray",
                    "suffix": ""
                },
                {
                    "first": "HF",
                    "middle": [],
                    "last": "Sneddon",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Craig",
                    "suffix": ""
                },
                {
                    "first": "AJB",
                    "middle": [],
                    "last": "Watson",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Green Chem",
            "volume": "15",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1039/c2gc36900a"
                ]
            }
        },
        "BIBREF22": {
            "title": "",
            "authors": [
                {
                    "first": "E",
                    "middle": [],
                    "last": "De Clercq",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Holy",
                    "suffix": ""
                }
            ],
            "year": 2005,
            "venue": "Nat Rev Drug Discov",
            "volume": "4",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1038/nrd1877"
                ]
            }
        },
        "BIBREF23": {
            "title": "",
            "authors": [
                {
                    "first": "",
                    "middle": [],
                    "last": "Basavaprabhu",
                    "suffix": ""
                },
                {
                    "first": "TM",
                    "middle": [],
                    "last": "Vishwanatha",
                    "suffix": ""
                },
                {
                    "first": "NR",
                    "middle": [],
                    "last": "Panguluri",
                    "suffix": ""
                },
                {
                    "first": "VV",
                    "middle": [],
                    "last": "Sureshbabu",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Synthesis",
            "volume": "45",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1055/s-0033-1338989"
                ]
            }
        },
        "BIBREF24": {
            "title": "",
            "authors": [
                {
                    "first": "JC",
                    "middle": [],
                    "last": "Sheehan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Preston",
                    "suffix": ""
                },
                {
                    "first": "PA",
                    "middle": [],
                    "last": "Cruickshank",
                    "suffix": ""
                }
            ],
            "year": 1965,
            "venue": "J Am Chem Soc",
            "volume": "87",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/ja01089a034"
                ]
            }
        },
        "BIBREF25": {
            "title": "",
            "authors": [
                {
                    "first": "S",
                    "middle": [],
                    "last": "Nozaki",
                    "suffix": ""
                }
            ],
            "year": 1999,
            "venue": "J Pept Res",
            "volume": "54",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1034/j.1399-3011.1999.00101.x"
                ]
            }
        },
        "BIBREF26": {
            "title": "",
            "authors": [
                {
                    "first": "B",
                    "middle": [],
                    "last": "Doboszewski",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Groaz",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Herdewijn",
                    "suffix": ""
                }
            ],
            "year": 2013,
            "venue": "Eur J Org Chem",
            "volume": "2013",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1002/ejoc.201300523"
                ]
            }
        },
        "BIBREF27": {
            "title": "",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Hockova",
                    "suffix": ""
                },
                {
                    "first": "DT",
                    "middle": [],
                    "last": "Keough",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Janeba",
                    "suffix": ""
                },
                {
                    "first": "TH",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "de Jersey",
                    "suffix": ""
                },
                {
                    "first": "LW",
                    "middle": [],
                    "last": "Guddat",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "J Med Chem",
            "volume": "55",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/jm300662d"
                ]
            }
        },
        "BIBREF28": {
            "title": "",
            "authors": [
                {
                    "first": "X",
                    "middle": [],
                    "last": "Pan",
                    "suffix": ""
                },
                {
                    "first": "C",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "F",
                    "middle": [],
                    "last": "Wang",
                    "suffix": ""
                },
                {
                    "first": "Z",
                    "middle": [],
                    "last": "Hu",
                    "suffix": ""
                },
                {
                    "first": "Y",
                    "middle": [],
                    "last": "Shan",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Zhang",
                    "suffix": ""
                }
            ],
            "year": 2011,
            "venue": "Curr Med Chem",
            "volume": "18",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.2174/092986711797287584"
                ]
            }
        },
        "BIBREF29": {
            "title": "",
            "authors": [
                {
                    "first": "H",
                    "middle": [],
                    "last": "Pischel",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Holy",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Vesely",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Wagner",
                    "suffix": ""
                },
                {
                    "first": "D",
                    "middle": [],
                    "last": "Cech",
                    "suffix": ""
                }
            ],
            "year": 1982,
            "venue": "Coll Czech Chem Commun",
            "volume": "47",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1135/cccc19822806"
                ]
            }
        },
        "BIBREF30": {
            "title": "",
            "authors": [
                {
                    "first": "AJ",
                    "middle": [],
                    "last": "Wiemer",
                    "suffix": ""
                },
                {
                    "first": "DF",
                    "middle": [],
                    "last": "Wiemer",
                    "suffix": ""
                }
            ],
            "year": 2015,
            "venue": "Top Curr Chem",
            "volume": "360",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1007/128_2014_561"
                ]
            }
        },
        "BIBREF31": {
            "title": "",
            "authors": [
                {
                    "first": "WC",
                    "middle": [],
                    "last": "Magee",
                    "suffix": ""
                },
                {
                    "first": "DH",
                    "middle": [],
                    "last": "Evans",
                    "suffix": ""
                }
            ],
            "year": 2012,
            "venue": "Antiviral Res",
            "volume": "96",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.antiviral.2012.08.010"
                ]
            }
        },
        "BIBREF32": {
            "title": "",
            "authors": [
                {
                    "first": "L",
                    "middle": [],
                    "last": "Holm",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Bockermann",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Wellner",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Baecklund",
                    "suffix": ""
                },
                {
                    "first": "R",
                    "middle": [],
                    "last": "Holmdahl",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kihlberg",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Bioorg Med Chem",
            "volume": "14",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/j.bmc.2006.05.023"
                ]
            }
        },
        "BIBREF33": {
            "title": "",
            "authors": [
                {
                    "first": "D",
                    "middle": [],
                    "last": "Blomberg",
                    "suffix": ""
                },
                {
                    "first": "P",
                    "middle": [],
                    "last": "Kreye",
                    "suffix": ""
                },
                {
                    "first": "CS",
                    "middle": [],
                    "last": "Fowler",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Brickmann",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kihlberg",
                    "suffix": ""
                }
            ],
            "year": 2006,
            "venue": "Org Biomol Chem",
            "volume": "4",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1039/b515618a"
                ]
            }
        },
        "BIBREF34": {
            "title": "",
            "authors": [
                {
                    "first": "M",
                    "middle": [],
                    "last": "Hedenstr\u00f6m",
                    "suffix": ""
                },
                {
                    "first": "ZQ",
                    "middle": [],
                    "last": "Yuan",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Brickmann",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Carlsson",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Ekholm",
                    "suffix": ""
                },
                {
                    "first": "B",
                    "middle": [],
                    "last": "Johansson",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Kreutz",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Nilsson",
                    "suffix": ""
                },
                {
                    "first": "I",
                    "middle": [],
                    "last": "Sethson",
                    "suffix": ""
                },
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kihlberg",
                    "suffix": ""
                }
            ],
            "year": 2002,
            "venue": "J Med Chem",
            "volume": "45",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1021/jm011073b"
                ]
            }
        },
        "BIBREF35": {
            "title": "",
            "authors": [
                {
                    "first": "A",
                    "middle": [],
                    "last": "Peyman",
                    "suffix": ""
                },
                {
                    "first": "E",
                    "middle": [],
                    "last": "Uhlmann",
                    "suffix": ""
                },
                {
                    "first": "K",
                    "middle": [],
                    "last": "Wagner",
                    "suffix": ""
                },
                {
                    "first": "S",
                    "middle": [],
                    "last": "Augustin",
                    "suffix": ""
                },
                {
                    "first": "G",
                    "middle": [],
                    "last": "Breipohl",
                    "suffix": ""
                },
                {
                    "first": "DW",
                    "middle": [],
                    "last": "Will",
                    "suffix": ""
                },
                {
                    "first": "A",
                    "middle": [],
                    "last": "Schaefer",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Wallmeier",
                    "suffix": ""
                }
            ],
            "year": 1996,
            "venue": "Angew Chem Int Ed",
            "volume": "35",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1002/anie.199626361"
                ]
            }
        },
        "BIBREF36": {
            "title": "",
            "authors": [
                {
                    "first": "J",
                    "middle": [],
                    "last": "Kehler",
                    "suffix": ""
                },
                {
                    "first": "U",
                    "middle": [],
                    "last": "Henriksen",
                    "suffix": ""
                },
                {
                    "first": "H",
                    "middle": [],
                    "last": "Vejbjerg",
                    "suffix": ""
                },
                {
                    "first": "O",
                    "middle": [],
                    "last": "Dahl",
                    "suffix": ""
                }
            ],
            "year": 1998,
            "venue": "Bioorg Med Chem",
            "volume": "6",
            "issn": "",
            "pages": null,
            "other_ids": {
                "DOI": [
                    "10.1016/S0968-0896(97)10041-4"
                ]
            }
        }
    }
}